VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

68 hedge funds and large institutions have $65.1M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$143K
Puts
$341K
Net Calls
Net Calls Change

Top Buyers

1 +$1.99M
2 +$1.26M
3 +$1.04M
4
Two Sigma Investments
Two Sigma Investments
New York
+$582K
5
Renaissance Technologies
Renaissance Technologies
New York
+$422K

Top Sellers

1 -$5.85M
2 -$3.6M
3 -$2.07M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$2.05M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$242K
27
$221K
28
$189K
29
$176K
30
$159K
31
$128K
32
$128K
33
$119K
34
$110K
35
$107K
36
$106K
37
$104K
38
$100K
39
$98K
40
$80K
41
$80K
42
$75K
43
$71K
44
$70K
45
$63K
46
$62K
47
$51K
48
$49K
49
$47K
50
$44K